Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges and issues in new vaccine development.

Philippe Moingeon1, Claude Leclerc

  • 1Aventis Pasteur, Campus Mérieux, 1541 Av. Marcel-Mérieux, 69280 l'Etoile, Marcy, France. philippe.moingeon@aventis.com

Trends in Immunology
|March 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital twins to accelerate target identification and drug development for immune-mediated disorders.

FEBS open bio·2026
Same author

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Annals of the rheumatic diseases·2025
Same author

Identifying Therapeutic Targets for Amyotrophic Lateral Sclerosis Through Modeling of Multi-Omics Data.

International journal of molecular sciences·2025
Same author

Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis.

The FEBS journal·2025
Same author

Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohort.

PloS one·2025
Same author

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).

Annals of the rheumatic diseases·2025

This conference focused on vaccine development, covering rational design to clinical application. Experts discussed future vaccine strategies and their translation into practice.

Area of Science:

  • Immunology and Vaccinology
  • Biotechnology and Pharmaceutical Sciences

Background:

  • The Euroconference convened experts to discuss advancements in vaccine research and development.
  • The event aimed to bridge the gap between scientific design and clinical implementation of vaccines.

Framework:

  • Focus on rational vaccine design principles.
  • Exploration of innovative approaches for vaccine development.
  • Discussion on the translation of research into clinical practice.

Implementation:

  • Held at the Pasteur Institute, Paris, France.
  • Took place from October 17-19, 2001.
  • Facilitated knowledge exchange among international researchers and clinicians.

Implications:

Related Experiment Videos

  • Advanced understanding of future vaccine development pathways.
  • Promoted collaboration in vaccinology research.
  • Contributed to the strategic planning of vaccine clinical trials.